2Seventy Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . 2Seventy Bio
TSVT Stock  USD 2.62  0.13  5.22%   
2Seventy Bio financial statements provide useful quarterly and yearly information to potential 2Seventy Bio investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on 2Seventy Bio financial statements helps investors assess 2Seventy Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting 2Seventy Bio's valuation are summarized below:
Gross Profit
-90.7 M
Profit Margin
(2.07)
Market Capitalization
135.2 M
Enterprise Value Revenue
4.0224
Revenue
45.6 M
There are currently one hundred twenty fundamental signals for 2Seventy Bio that can be evaluated and compared over time across rivals. All traders should validate 2Seventy Bio's prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction.

2Seventy Bio Total Revenue

108.79 Million

Check 2Seventy Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 2Seventy Bio's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 12.4 M or Depreciation And Amortization of 10.7 M, as well as many indicators such as Price To Sales Ratio of 2.29, Dividend Yield of 0.0 or PTB Ratio of 0.9. 2Seventy financial statements analysis is a perfect complement when working with 2Seventy Bio Valuation or Volatility modules.
  
Check out the analysis of 2Seventy Bio Correlation against competitors.
For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.

2Seventy Bio Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding32.7 M56.7 M28.4 M
Slightly volatile
Total Assets574.1 M650.2 M416.8 M
Slightly volatile
Short and Long Term Debt Total235.5 M295.2 M175.2 M
Slightly volatile
Other Current Liabilities38.9 M23.1 M54.6 M
Slightly volatile
Total Current Liabilities66.8 M53.8 M91.8 M
Slightly volatile
Total Stockholder Equity229.7 M293.6 M122.5 M
Slightly volatile
Other Liabilities6.3 M6.7 M35.2 M
Slightly volatile
Net Tangible Assets194.1 M334.8 M107.3 M
Slightly volatile
Property Plant And Equipment Net308.7 M319.8 M271.8 M
Slightly volatile
Current Deferred Revenue18.6 M17.7 M9.1 M
Slightly volatile
Net Debt168.8 M163.5 M237 M
Slightly volatile
Accounts Payable7.5 M5.4 M15.2 M
Slightly volatile
Non Current Assets Total381.3 M376.8 M321.1 M
Slightly volatile
Non Currrent Assets Other30.2 M43.9 M21.1 M
Slightly volatile
Net Receivables15.3 M15.4 M10.4 M
Slightly volatile
Good Will10 M10.9 M12.6 M
Slightly volatile
Liabilities And Stockholders Equity574.1 M650.2 M416.8 M
Slightly volatile
Non Current Liabilities Total252.6 M287.9 M200 M
Slightly volatile
Capital Lease Obligations235.5 M295.2 M175.2 M
Slightly volatile
Other Current Assets7.2 M6.6 M11.2 M
Slightly volatile
Total Liabilities344.4 M356.6 M294.2 M
Slightly volatile
Net Invested Capital229.7 M293.6 M122.5 M
Slightly volatile
Property Plant And Equipment Gross351.7 M385.3 M302.5 M
Slightly volatile
Total Current Assets192.8 M273.4 M95.6 M
Slightly volatile
Non Current Liabilities Other2.6 M2.8 M40.8 M
Very volatile
Short Term Debt21.8 M30.4 M15.8 M
Slightly volatile
Intangible Assets6.2 M5.9 M8.5 M
Slightly volatile
Common Stock4.3 K4.5 K32 M
Slightly volatile
Property Plant Equipment47.7 M50.2 M192.5 M
Slightly volatile
Common Stock Total Equity3.3 K4.6 K2.5 K
Slightly volatile
Capital Surpluse553.9 M698 M454.1 M
Slightly volatile

2Seventy Bio Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization10.7 M9.3 M12.9 M
Slightly volatile
Selling General Administrative86.4 M82.7 M66.8 M
Slightly volatile
Total Revenue108.8 M115.4 M78.4 M
Slightly volatile
Gross Profit98.7 M96 M72.7 M
Slightly volatile
Other Operating Expenses226.9 M285.4 M265.9 M
Very volatile
Research Development204.8 M207.7 M222 M
Slightly volatile
Cost Of Revenue10.1 M19.5 M5.7 M
Slightly volatile
Total Operating Expenses373.7 M369.2 M300.9 M
Slightly volatile
Reconciled Depreciation10.2 M8.6 M12.6 M
Slightly volatile
Non Operating Income Net Other5.2 M5.4 M17.7 M
Slightly volatile

2Seventy Bio Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation38.9 M28.9 M42.9 M
Very volatile
Other Cashflows From Financing Activities450.6 K474.3 K156.1 M
Slightly volatile
Depreciation10.3 M9.3 M12.7 M
Slightly volatile
Capital Expenditures11.9 M12.5 M38.8 M
Slightly volatile
Total Cash From Financing Activities160.4 M114.7 M190.9 M
Pretty Stable
Change To Netincome41.7 M37.2 M45.8 M
Very volatile
Sale Purchase Of Stock208.2 M149 M309.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.292.415.1839
Slightly volatile
PTB Ratio0.90.955.195
Slightly volatile
Days Sales Outstanding51.6943.8960.5851
Very volatile
Book Value Per Share5.484.663.8285
Slightly volatile
Stock Based Compensation To Revenue0.350.370.6791
Slightly volatile
Capex To Depreciation2.711.553.0938
Slightly volatile
PB Ratio0.90.955.195
Slightly volatile
EV To Sales8.624.4910.7335
Slightly volatile
Payables Turnover1.512.530.9243
Slightly volatile
Research And Ddevelopement To Revenue3.932.643.5854
Pretty Stable
Capex To Revenue0.150.160.6798
Slightly volatile
Days Payables Outstanding1421501.6 K
Slightly volatile
Income Quality0.580.690.7175
Pretty Stable
Intangibles To Total Assets0.01270.01340.0545
Slightly volatile
Current Ratio1.83.581.1524
Slightly volatile
Tangible Book Value Per Share4.944.543.0316
Slightly volatile
Receivables Turnover9.748.617.2667
Pretty Stable
Graham Number26.9420.4227.1017
Pretty Stable
Shareholders Equity Per Share5.484.663.8285
Slightly volatile
Debt To Equity1.641.162.3589
Slightly volatile
Capex Per Share0.310.321.5967
Slightly volatile
Revenue Per Share4.02.342.9317
Pretty Stable
Interest Debt Per Share5.754.696.1272
Pretty Stable
Debt To Assets0.330.410.4141
Slightly volatile
Price Book Value Ratio0.90.955.195
Slightly volatile
Days Of Payables Outstanding1421501.6 K
Slightly volatile
Ebt Per Ebit0.750.90.9481
Slightly volatile
Company Equity Multiplier3.932.555.5746
Slightly volatile
Long Term Debt To Capitalization0.650.50.6507
Slightly volatile
Total Debt To Capitalization0.620.580.6733
Slightly volatile
Debt Equity Ratio1.641.162.3589
Slightly volatile
Net Income Per E B T1.131.151.0288
Slightly volatile
Days Of Sales Outstanding51.6943.8960.5851
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.331.251.2874
Slightly volatile
Price To Book Ratio0.90.955.195
Slightly volatile
Fixed Asset Turnover0.430.420.273
Slightly volatile
Debt Ratio0.330.410.4141
Slightly volatile
Price Sales Ratio2.292.415.1839
Slightly volatile
Asset Turnover0.290.20.1924
Pretty Stable
Gross Profit Margin0.960.83150.9374
Slightly volatile
Price Fair Value0.90.955.195
Slightly volatile

2Seventy Bio Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap322.4 M242 M295.2 M
Slightly volatile
Enterprise Value640 M662.3 M592.7 M
Slightly volatile

2Seventy Fundamental Market Drivers

Cash And Short Term Investments217 M

2Seventy Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About 2Seventy Bio Financial Statements

2Seventy Bio shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although 2Seventy Bio investors may analyze each financial statement separately, they are all interrelated. The changes in 2Seventy Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on 2Seventy Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue17.7 M18.6 M
Total Revenue115.4 M108.8 M
Cost Of Revenue19.5 M10.1 M
Stock Based Compensation To Revenue 0.37  0.35 
Research And Ddevelopement To Revenue 2.64  3.93 
Capex To Revenue 0.16  0.15 
Revenue Per Share 2.34  4.00 
Ebit Per Revenue(1.94)(2.04)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for 2Seventy Stock Analysis

When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY